1194065

Novo Nordisk Inc. — FEI 2244771

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 21, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plainsboro, NJ (United States)

Additional Details

Sponsor, Contract Research Organization